European journal of pharmacology · 2026
Spinosin attenuates DSS-induced ulcerative colitis in rats in association with increased Nrf2/HO-1 and reduced TLR4/NFKB1-related inflammatory markers.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Qnais Esam, Bseiso Yousra, Alqudah Abdelrahim, Rabeh Mohammad E, Rabi Ahmad M, Aljabali Alaa A A, Badran Tuleen, Oqal Muna, Gammoh Omar, Shilbayeh Sireen Abdul Rahim
Аннотация
BACKGROUND: Ulcerative colitis involves epithelial injury, oxidative stress, and exaggerated inflammatory signaling. This study evaluated the protective effects of spinosin in dextran sulfate sodium (DSS)-induced colitis in rats.
METHODS: Colitis was induced using 2% DSS in drinking water. Rats received oral spinosin (5, 10, or 20 mg/kg) or sulfasalazine once daily. Clinical indices, macroscopic injury, oxidative/nitrosative stress, inflammatory mediators, Nrf2/HO-1-related markers, TLR4/NFKB1-associated markers, apoptosis-related proteins, MCP-1, and tight junction gene expression were assessed.
RESULTS: DSS caused body-weight loss, colon shortening, splenomegaly, increased disease activity index (DAI), oxidative/nitrosative stress, inflammatory mediator upregulation, and reduced tight junction gene expression. Spinosin improved day-8 body weight at 10 mg/kg (p < 0.05) and 20 mg/kg (p < 0.001), restored colon length at 10 and 20 mg/kg (p < 0.001), reduced spleen index at 20 mg/kg (p < 0.001), and decreased DAI at all doses (p < 0.001). Spinosin reduced LDH at 5 mg/kg (p < 0.05) and 10-20 mg/kg (p < 0.001), and reduced MPO, MDA, NO, COX-2, iNOS, and MCP-1. Spinosin reduced IL-6, TNF-α, TGF-β, PGE₂, Bax, NFKB1 p105/p50 protein levels, and TLR4 mRNA expression, with the most consistent effects observed at 10 and 20 mg/kg. Spinosin also increased antioxidant defenses, HO-1, Nrf2, IL-10, Bcl-2, and ZO-1/occludin mRNA expression, mainly at 10-20 mg/kg (p < 0.001).
CONCLUSIONS: Spinosin attenuates DSS-induced colitis in rats, with effects associated with improved redox balance, increased Nrf2/HO-1-related cytoprotective markers, reduced inflammatory mediators, and restored barrier-associated gene expression.
METHODS: Colitis was induced using 2% DSS in drinking water. Rats received oral spinosin (5, 10, or 20 mg/kg) or sulfasalazine once daily. Clinical indices, macroscopic injury, oxidative/nitrosative stress, inflammatory mediators, Nrf2/HO-1-related markers, TLR4/NFKB1-associated markers, apoptosis-related proteins, MCP-1, and tight junction gene expression were assessed.
RESULTS: DSS caused body-weight loss, colon shortening, splenomegaly, increased disease activity index (DAI), oxidative/nitrosative stress, inflammatory mediator upregulation, and reduced tight junction gene expression. Spinosin improved day-8 body weight at 10 mg/kg (p < 0.05) and 20 mg/kg (p < 0.001), restored colon length at 10 and 20 mg/kg (p < 0.001), reduced spleen index at 20 mg/kg (p < 0.001), and decreased DAI at all doses (p < 0.001). Spinosin reduced LDH at 5 mg/kg (p < 0.05) and 10-20 mg/kg (p < 0.001), and reduced MPO, MDA, NO, COX-2, iNOS, and MCP-1. Spinosin reduced IL-6, TNF-α, TGF-β, PGE₂, Bax, NFKB1 p105/p50 protein levels, and TLR4 mRNA expression, with the most consistent effects observed at 10 and 20 mg/kg. Spinosin also increased antioxidant defenses, HO-1, Nrf2, IL-10, Bcl-2, and ZO-1/occludin mRNA expression, mainly at 10-20 mg/kg (p < 0.001).
CONCLUSIONS: Spinosin attenuates DSS-induced colitis in rats, with effects associated with improved redox balance, increased Nrf2/HO-1-related cytoprotective markers, reduced inflammatory mediators, and restored barrier-associated gene expression.